Last reviewed · How we verify
Phyliance (fytic acid)
At a glance
| Generic name | fytic acid |
|---|---|
| Sponsor | PDRadiopharma Inc |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
Approved indications
- Lymphoscintigraphy in cervical cancer, uterine neoplasms, vulvar cancer, and head and neck canccer
- Malignant tumor of vulva
- Sentinel lymph node mapping
Common side effects
Key clinical trials
- Zinc and Iron Absorption From Common Beans in Young Adult Women (NA)
- Evaluation of Patient Satisfaction With Blephaderm as a Complementary Care in Post-eyelid Surgery.
- Iron Absorption From Naturally Dephytinized Legumes (NA)
- Maternal Under-nutrition and Effect of Amaranth Grain Flat-bread on Anemia (PHASE3)
- Efficacy of Chinese Herbal Medicine Xiaojidaozhi Decoction in the Treatment of Childhood Constipation (EARLY_PHASE1)
- Efficacy of Melanostop Peeling for Improvement of Melasma (NA)
- Zinc Deficiency Treatment in Celiac Disease: Supplementation Versus Diet (NA)
- Effects of Dietary Folate and Phytate Zinc Absorption: Zinc Amino Acid Complexes vs. Zinc-chloride (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Phyliance CI brief — competitive landscape report
- Phyliance updates RSS · CI watch RSS
- PDRadiopharma Inc portfolio CI